Standout Papers

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 c... 2007 2026 2013 2019 780
  1. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (2007)
    Lu Zhang, Ferenc Martényi et al. Nature Medicine

Immediate Impact

4 by Nobel laureates 20 from Science/Nature 60 standout
Sub-graph 1 of 20

Citing Papers

Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
2023 StandoutScience
Late-stage diversification of indole skeletons through nitrogen atom insertion
2022 StandoutScience
3 intermediate papers

Works of Morozova Ma being referenced

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
2007 Standout

Author Peers

Author Last Decade Papers Cites
Morozova Ma 604 217 163 708 545 60 1.5k
Smulevich Ab 493 178 111 593 425 72 1.2k
T B Cooper 708 124 203 591 427 35 1.8k
Seiya Miyamoto 768 325 304 842 650 45 2.1k
L. Bjerkenstedt 708 282 198 455 353 50 1.4k
Giovanni Muscettola 544 158 255 524 339 62 1.7k
Anne‐Noël Samaha 443 96 123 873 387 42 1.4k
Karu Jayathilake 1072 258 239 582 496 42 2.1k
Н. Г. Незнанов 315 222 153 675 489 106 1.4k
David L. Garver 976 349 257 590 429 82 2.2k
Baron Shopsin 1028 317 414 631 336 78 2.1k

All Works

Loading papers...

Rankless by CCL
2026